drugset / Trial / NCT06514547

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

NCT06514547 ↗

NaSingle-groupOpen-labelBasic science

Summary

This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.

Timeline

Start
2024-07-08
Primary completion
2028-09-15
Completion
2029-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Conjugate Pneumococcal Vaccine 20 Vaccine — —